共2796个筛选结果
-
- 资料详情
- 价格
- 下载
-
-
SACI-0 HR A randomized phase ll trial ofsacituzumab govitecan with or without pembrolizumabin patients with metastatic hormone receptor-positive!HER2-negative breast cancer.
大小:5.14 MB | 浏览:389 -
Racial differences in genomic profilesand targeted treatment use in ER HER2-metastatic breast cancer.
大小:2.36 MB | 浏览:376 - 价格:15 微豆
-
Outcomes of Advanced MetastaticBreast Cancer(aMBC) Treated with Bria-lMT, an Allogeneic Whole-cell Immunotherapy.
大小:5.24 MB | 浏览:368 -
LBA1000 DESTINY-Breast06.
大小:6.12 MB | 浏览:390
-